Quarterly report · Q3

Period2022-04-01 → 2022-12-31
Filed2023-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥3.9bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥4.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥3.5bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥734m2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥700m2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥746m2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥1.1bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥714m2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥640m2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥703m2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥414m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥832m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥521m2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥414m2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥521m2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥5.7bnat 2022-12-31Cons.Assets
Total assets¥5.6bnat 2022-03-31Cons.Assets
Total assets¥4.9bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥1.7bnat 2022-12-31Cons.Liabilities
Total liabilities¥1.8bnat 2022-03-31Cons.Liabilities
Net assets / equity¥4.0bnat 2022-12-31Cons.Net assets
Net assets / equity¥3.8bnat 2022-03-31Cons.Net assets
Net assets / equity¥3.4bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥3.6bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥3.4bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥35.052022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥6.472022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥70.382021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥44.12021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.472021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥34.22022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥68.492021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥42.892021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio70.1%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio67.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio69.6%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 39
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥300,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥300,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥150,000
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥33m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥33m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥240m
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue2022-04-01 → 2022-12-31¥2.8bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.8bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥33m
jpcrp040300-q3r_E32408-000Globalreportable segmentsegment profit2022-04-01 → 2022-12-31¥312m
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentsegment profit2022-04-01 → 2022-12-31¥662m
—segment totalrevenue2022-04-01 → 2022-12-31¥3.9bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥3.9bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥33m
—segment totalsegment profit2022-04-01 → 2022-12-31¥974m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥33m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥974m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥61m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥61m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥236m
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue2021-04-01 → 2021-12-31¥2.4bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue external2021-04-01 → 2021-12-31¥2.3bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥61m
jpcrp040300-q3r_E32408-000Globalreportable segmentsegment profit2021-04-01 → 2021-12-31¥308m
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue2021-04-01 → 2021-12-31¥1.1bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue external2021-04-01 → 2021-12-31¥1.1bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentsegment profit2021-04-01 → 2021-12-31¥627m
—segment totalrevenue2021-04-01 → 2021-12-31¥3.5bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥3.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥61m
—segment totalsegment profit2021-04-01 → 2021-12-31¥935m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥3.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥3.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥61m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥935m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 351
ItemContextValueUnit
Other clPrior1YearInstant327866000JPY
Other clCurrentQuarterInstant312227000JPY
Current liabilitiesPrior1YearInstant1464532000JPY
Current liabilitiesCurrentQuarterInstant1286319000JPY
Lease obligations nclPrior1YearInstant137566000JPY
Lease obligations nclCurrentQuarterInstant81068000JPY
Deferred tax liabilitiesPrior1YearInstant169847000JPY
Deferred tax liabilitiesCurrentQuarterInstant197534000JPY
Net defined benefit liabilityPrior1YearInstant32173000JPY
Net defined benefit liabilityCurrentQuarterInstant110062000JPY
Asset retirement obligations nclPrior1YearInstant7522000JPY
Asset retirement obligations nclCurrentQuarterInstant21625000JPY
Noncurrent liabilitiesPrior1YearInstant347110000JPY
Noncurrent liabilitiesCurrentQuarterInstant410290000JPY
LiabilitiesPrior1YearInstant1811642000JPY
LiabilitiesCurrentQuarterInstant1696610000JPY
Capital stockPrior1YearInstant788949000JPY
Capital stockCurrentQuarterInstant795078000JPY
Capital surplusPrior1YearInstant693565000JPY
Capital surplusCurrentQuarterInstant699694000JPY
Retained earningsPrior1YearInstant2270297000JPY
Retained earningsCurrentQuarterInstant2577470000JPY
Treasury stockPrior1YearInstant-25588000JPY
Treasury stockCurrentQuarterInstant-168649000JPY
Shareholders equityPrior1YearInstant3727224000JPY
Shareholders equityCurrentQuarterInstant3903593000JPY
Valuation difference on available for sale securitiesPrior1YearInstant12936000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant35504000JPY
Foreign currency translation adjustmentPrior1YearInstant62731000JPY
Foreign currency translation adjustmentCurrentQuarterInstant92443000JPY
Remeasurements of defined benefit plansPrior1YearInstant9451000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-58454000JPY
Valuation and translation adjustmentsPrior1YearInstant85118000JPY
Valuation and translation adjustmentsCurrentQuarterInstant69492000JPY
Subscription rights to sharesPrior1YearInstant182000JPY
Subscription rights to sharesCurrentQuarterInstant174000JPY
Net assetsPrior1YearInstant3812525000JPY
Net assetsCurrentQuarterInstant3973261000JPY
Liabilities and net assetsPrior1YearInstant5624167000JPY
Liabilities and net assetsCurrentQuarterInstant5669871000JPY
Net salesPrior1YTDDuration3452771000JPY
Net salesCurrentYTDDuration3910774000JPY
Cost of salesPrior1YTDDuration2029354000JPY
Cost of salesCurrentYTDDuration2391920000JPY
Gross profitPrior1YTDDuration1423417000JPY
Gross profitCurrentYTDDuration1518853000JPY
Selling general and administrative expensesPrior1YTDDuration723517000JPY
Selling general and administrative expensesCurrentYTDDuration784898000JPY
Operating incomePrior1YTDDuration699899000JPY
Operating incomeCurrentYTDDuration733954000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass